Stocks in Focus on January 14: Avenue Supermarket, TSIL to Jet Airways; here are the 5 newsmakers of the day
Avenue Supermarts Ltd: The operator of retail chain DMart, Avenue Supermarts Ltd., has posted Q3FY19 results and reported that its revenue went up to Rs 5451-crore from Rs 4094-crore (YoY). Its net profit went up to Rs 257.1-crore from Rs 251.8-crore (YoY), which is the slowest growth in eight quarters. However, its margin declined to 8.3 per cent from 10.3 per cent.
Indian stock closed in a red on January 11, 2019, but there were certain stocks that came in the news after the market was closed for the day. These stocks may have an impact on the market after it is reopened for trade on Monday, January 14, 2019. Here is the list of five such stocks:
Avenue Supermarts Ltd: The operator of retail chain DMart, Avenue Supermarts Ltd., has posted Q3FY19 results and reported that its revenue went up to Rs 5451-crore from Rs 4094-crore (YoY). Its net profit went up to Rs 257.1-crore from Rs 251.8-crore (YoY), which is the slowest growth in eight quarters. However, its margin declined to 8.3 per cent from 10.3 per cent.
Tata Sponge Iron Ltd. (TSIL): TSIL has presented its financial results for Q3FY19 and reported that its net profit went down from Rs 36-crore to Rs 27-crore (YoY) while the revenue went up from Rs 214-crore to Rs 261-crore. A significant erosion was seen in EBITDA margins went down to 11.7 per cent from 22.2 per cent.
Jet Airways Ltd: Crisis talks to ease a row over late payments between the cash-strapped Jet Airways and its lessors have failed to reach a conclusion promoting some lessors to explore taking back aircraft. Earlier, the airline had told some lessors it would clear arrears by December 31, 2018, but was unable do so.
IL&FS Engineering & Construction: The Gujarat Metro Rail Corporation has terminated the Rs 374.65-crore contract awarded to the company due citing project delays and awarded the same to J Kumar Infrastructure. The company was previously awarded a contract to build four stations and lay a 4.6-km viaduct for the metro project in the city.
Sun Pharma/ SPARC: The company on Friday said that it has launched Xelpros in the US markets. Xelpros is indicated in the treatment of open-angle glaucoma or ocular hypertension. The company in September 2018, had received USFDA approval for their drug Xelpros (Latanoprost ophthalmic emulsion).
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.